D. C. Guven Et Al. , "The efficacy of immunotherapy and chemoimmunotherapy in patients with advanced rare tumors: A Turkish oncology group (TOG) study.," Cancer medicine , 2023
Guven, D. C. Et Al. 2023. The efficacy of immunotherapy and chemoimmunotherapy in patients with advanced rare tumors: A Turkish oncology group (TOG) study.. Cancer medicine .
Guven, D. C., Aykan, M. B., Muglu, H., Bayram, E., Helvaci, K., Dursun, B., ... Celayir, M.(2023). The efficacy of immunotherapy and chemoimmunotherapy in patients with advanced rare tumors: A Turkish oncology group (TOG) study.. Cancer medicine .
Guven, Deniz Et Al. "The efficacy of immunotherapy and chemoimmunotherapy in patients with advanced rare tumors: A Turkish oncology group (TOG) study.," Cancer medicine , 2023
Guven, Deniz C. Et Al. "The efficacy of immunotherapy and chemoimmunotherapy in patients with advanced rare tumors: A Turkish oncology group (TOG) study.." Cancer medicine , 2023
Guven, D. C. Et Al. (2023) . "The efficacy of immunotherapy and chemoimmunotherapy in patients with advanced rare tumors: A Turkish oncology group (TOG) study.." Cancer medicine .
@article{article, author={Deniz Can Guven Et Al. }, title={The efficacy of immunotherapy and chemoimmunotherapy in patients with advanced rare tumors: A Turkish oncology group (TOG) study.}, journal={Cancer medicine}, year=2023}